A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers.

Othman, Ahmed A; Cheskin, Howard; Locke, Charles; Nothaft, Wolfram; Dutta, Sandeep

Othman, Ahmed A; Cheskin, Howard; Locke, Charles; Nothaft, Wolfram; Dutta, Sandeep.

Afiliación

Othman AA; Abbott Laboratories, Abbott Park, IL, USA.
Cheskin H; Abbott Laboratories, Abbott Park, IL, USA.
Locke C; Abbott Laboratories, Abbott Park, IL, USA.
Nothaft W; Abbott Laboratories, Abbott Park, IL, USA.
Dutta S; Abbott Laboratories, Abbott Park, IL, USA.

Clin Pharmacol Drug Dev ; 1(1): 24-31, 2012 Jan.

Article en En | MEDLINE | ID: mdl-27206143

Palabras clave

ABT102; bioavailability; food effect; formulation; meltextrusion; spraydried

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google